持田製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4534/E00947 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2015/01/16 | 日証協 | 170,545株 | +31.24% | 94,356株 | +36.95% | 224,088株 | +55.31% | 83,056株 | +1571.82% |
2015/01/09 | 日証協 | 129,945株 | -25.91% | 68,900株 | +6790% | 144,284株 | -40.31% | 4,968株 | +60.26% |
2014/12/30 | 日証協 | 175,389株 | +0.11% | 1,000株 | -82.46% | 241,728株 | -2.42% | 3,100株 | -35.42% |
2014/12/26 | 日証協 | 175,189株 | -0.11% | 5,700株 | -95.26% | 247,728株 | +6.74% | 4,800株 | -96.1% |
2014/12/19 | 日証協 | 175,389株 | +45.93% | 120,244株 | +98.51% | 232,084株 | +95.71% | 123,144株 | +761.15% |
2014/12/12 | 日証協 | 120,189株 | +1.24% | 60,574株 | +225.4% | 118,584株 | +9.82% | 14,300株 | -27.8% |
2014/12/05 | 日証協 | 118,714株 | -4.73% | 18,615株 | -72.08% | 107,982株 | +13.69% | 19,805株 | +195.51% |
2014/11/28 | 日証協 | 124,614株 | +3.95% | 66,669株 | +1016.73% | 94,977株 | -1.28% | 6,702株 | +19.02% |
2014/11/21 | 日証協 | 119,875株 | +0.25% | 5,970株 | -92.1% | 96,208株 | +0.55% | 5,631株 | +333.15% |
2014/11/14 | 日証協 | 119,575株 | +2.75% | 75,545株 | +979.21% | 95,678株 | +0.1% | 1,300株 | -62.43% |
2014/11/07 | 日証協 | 116,375株 | +5.39% | 7,000株 | -82.17% | 95,578株 | +3.69% | 3,460株 | -65.4% |
2014/10/31 | 日証協 | 110,427株 | +24.94% | 39,252株 | -26.56% | 92,178株 | +21.95% | 10,001株 | -60.16% |
2014/10/24 | 日証協 | 88,385株 | -8.3% | 53,445株 | +24.54% | 75,584株 | -8.58% | 25,106株 | -13.14% |
2014/10/17 | 日証協 | 96,385株 | +53.1% | 42,915株 | +417.05% | 82,682株 | +14.44% | 28,904株 | +481.57% |
2014/10/10 | 日証協 | 62,954株 | -10.22% | 8,300株 | -81.96% | 72,249株 | -8.77% | 4,970株 | -59.26% |
2014/10/03 | 日証協 | 70,124株 | -6.11% | 46,014株 | +24.67% | 79,195株 | -14.47% | 12,200株 | -23.28% |
2014/09/26 | 日証協 | 74,688株 | -14.11% | 36,909株 | +117.51% | 92,595株 | -5.99% | 15,901株 | +341.57% |
2014/09/19 | 日証協 | 86,957株 | -3.55% | 16,969株 | -23.11% | 98,495株 | -6.64% | 3,601株 | -32.48% |
2014/09/12 | 日証協 | 90,157株 | -3.68% | 22,069株 | -9.55% | 105,495株 | -0.03% | 5,333株 | -20.59% |
※株式分割は考慮していませんのでご注意ください。
Page Top